Krystal Biotech, Inc.KRYSNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
5Y CAGR+73.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+73.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
15.5x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$28.77M+43.4%
2024$20.06M+548.4%
2023$3.09M-
2022$0.00-
2021$0.00-100.0%
2020$1.85M+90.0%
2019$974000.00+590.8%
2018$141000.00+513.0%
2017$23000.00+1050.0%
2016$2000.00-